Mycophenolate mofetil in liver transplantation for hepatitis C: Effect on recurrence and pharmacokinetics.

被引:0
|
作者
Ghobrial, RM
Holt, CD
Sievers, TM
Saab, S
Artinian, L
McDiarmid, SV
Busuttil, RW
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1601
引用
收藏
页码:598 / 598
页数:1
相关论文
共 50 条
  • [1] Mycophenolate Mofetil: Pharmacokinetics and effect on hepatitis C recurrence in liver transplantation.
    Ghobrial, RM
    Holt, CD
    Sievers, TM
    Saab, S
    McDiarmid, SV
    Artinian, L
    Busuttil, RW
    LIVER TRANSPLANTATION, 2005, 11 (07) : C4 - C4
  • [2] Mycophenolate mofetil: Pharmacokinetics and effect on hepatitis c recurrence in liver transplantation.
    Ghobrial, RM
    Holt, CD
    Sievers, TM
    Saab, S
    Artinian, L
    McDiarmid, SV
    Busuttil, RW
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 180 - 180
  • [3] Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation
    Kornberg, A
    Küpper, B
    Tannapfel, A
    Hommann, M
    Scheele, J
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (01) : 107 - 115
  • [4] Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1563 - 1564
  • [5] THE POSITIVE EFFECT OF MYCOPHENOLATE MOFETIL ON THE HISTOLOGY COURSE OF HEPATITIS C AFTER LIVER TRANSPLANTATION
    Manzia, Tommaso Maria
    Toti, Luca
    Lenci, Ilaria
    Angelico, Roberta
    Monaco, Andrea
    Manuelli, Matteo
    de Luca, Linda
    Tariciotti, Laura
    Tisone, Giuseppe
    TRANSPLANT INTERNATIONAL, 2009, 22 : 114 - 115
  • [6] Mycophenolate Mofetil's antiviral activity and influence on recurrence of hepatitis C following liver transplantation.
    Smallwood, GA
    Davis, L
    Stieber, A
    de Vera, M
    Heffron, TG
    HEPATOLOGY, 2000, 32 (04) : 343A - 343A
  • [7] The effects of delayed graft function on mycophenolate mofetil pharmacokinetics.
    van Gelder, Teun
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 162 - 162
  • [8] Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation
    Platz, KP
    Mueller, AR
    Willimski, C
    Mansoorian, B
    Berg, T
    Neuhaus, R
    Hopf, U
    Radke, C
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2232 - 2233
  • [9] Indications for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation
    Platz, KP
    Mueller, AR
    Willimski, C
    Mansoorian, B
    Berg, T
    Neuhaus, R
    Hopf, U
    Lobeck, H
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1468 - 1469
  • [10] Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Molmenti, EP
    Klintmalm, GB
    TRANSPLANTATION, 2000, 69 (08) : S120 - S120